Tatsis Ourania
CIK 0001789815
EVP, Chief Reg. & Quality Off.Director
Filings
38
Latest May 11, 2026
Issuers covered
3
Showing
38 of 38
Page 1
Track record
54 of 54 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 54 | 35% | -3.1% | -2.8% | +10.3% | -13.2% |
| 90 days | 54 | 22% | -6.9% | -9.5% | +10.8% | -17.1% |
| 180 days | 48 | 17% | -14.2% | -16.8% | +21.0% | -30.3% |
| 365 days | 47 | 11% | -25.8% | -27.4% | +5.0% | -49.9% |
Issuers
Companies where Tatsis Ourania has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc / Ma | 34 | Feb 26, 2026 |
| VERV | Verve Therapeutics, Inc. | 3 | Jul 28, 2025 |
| ODTX | Odyssey Therapeutics, Inc. | 1 | May 11, 2026 |
All filings
38 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|